Investing Profile

Ed Mathers

VCInvestor
Partner at New Enterprise Associates (NEA)
Photo of Ed Mathers, Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New Enterprise Associates (NEA) Network
42 CONNECTIONS
New Enterprise Associates Network
16 CONNECTIONS
cb
$2.0M - $50.0M
$25.0M
52
$6.2B
CompanyStageDateRound SizeTotal Raised
Affinia Therapeutics
Series COct 2025$40M
Series BMay 2021$110M
Series AMar 2020$60M
$210M
Co-investors: Robert Weisskoff (F-Prime Capital Partners), David Grayzel (Atlas Venture)
Splice Bio
Series BJun 2025$140M
Series AFeb 2022$57M
$190M
Co-investors: Sylvain Sachot (Asabys Partners), Joël Jean-Mairet (Ysios Capital), Beat Steffen (Novartis Venture Fund), Carole Nuechterlein (Roche Venture Fund), Daniela Begolo (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Orbis Medicines
Series AJan 2025$93M
$120M
Co-investors: Marco Boorsma (Forbion)
Brenig Therapeutics
Series AJul 2024$65M
$65M
Cardurion Pharmaceuticals
Series BJul 2024$260M
$260M
Co-investors: Amy Schulman (Polaris Partners)
MBX Biosciences
Series BNov 2022$120M
Series AJul 2020$35M
$150M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
Inversago Pharma
Series COct 2022$69M
$110M
Co-investors: Elizabeth Douville (Amorchem), Nanna Luneborg (Forbion), Marco Boorsma (Forbion)
Code Biotherapeutics
Series AJun 2022$75M
SeedApr 2021$10M
$85M
Co-investors: Dima Kuzmin (4BIO Capital), Victor Stone (Takeda Ventures), Diana Bernstein (Northpond Ventures)
Partner New Enterprise Associates (NEA)Present
Partner New Enterprise Associates2008 - Present
NC State University Bachelor of Science (BS)